Abstract:Graphical and Lay Summary Chinese hamster ovary (CHO) cells are the main host for biopharmaceuticals production. However, their growth and productivity can be negatively influenced by the accumulation of inhibitory by‐products from their metabolism. In this study, we demonstrate the impact of amino acid degradation pathway (AADP) by‐products in the growth, productivity, and proteome of high‐density CHO cell cultures. The cell line X2 was susceptible to these by‐products, while X1 showed similar growth patterns to an apoptosis‐resistant cell line (AB). Proteomics revealed changes in proteins linked to apoptosis regulation in X2 cultures after the addition of by‐products. We confirmed the activation of apoptosis through a caspase activity assay. These results provide insight into the cell death mechanisms triggered by AADP by‐products and contribute towards the optimization of CHO‐cell‐based biomanufacturing. Chinese hamster ovary (CHO) cells are widely used to produce complex biopharmaceuticals. Improving their productivity is necessary to fulfill the growing demand for such products. One way to enhance productivity is by cultivating cells at high densities, but inhibitory by‐products, such as metabolite derivatives from amino acid degradation, can hinder achieving high cell densities. This research examines the impact of these inhibitory by‐products on high‐density cultures. We cultured X1 and X2 CHO cell lines in a small‐scale semi‐perfusion system and introduced a mix of inhibitory by‐products on day 10. The X1 and X2 cell lines were chosen for their varied responses to the by‐products; X2 was susceptible, while X1 survived. Proteomics revealed that the X2 cell line presented changes in the proteins linked to apoptosis regulation, cell building block synthesis, cell growth, DNA repair, and energy metabolism. We later used the AB cell line, an apoptosis‐resistant cell line, to validate the results. AB behaved similar to X1 under stress. We confirmed the activation of apoptosis in X2 using a caspase assay. This research provides insights into the mechanisms of cell death triggered by inhibitory by‐products and can guide the optimization of CHO cell culture for biopharmaceutical manufacturing.

Antiapoptosis Engineering for Improved Protein Production from CHO Cells

Combining high-throughput screening of caspase activity with anti-apoptosis genes for development of robust CHO production cell lines

Evaluating apoptotic gene efficiency for CHO culture performance using targeted integration

Enhanced Production of Anti-Pd1 Antibody in CHO Cells Through Transient Co-Transfection with Anti-Apoptotic Genes Bcl-x L and Mcl-1.

Strategies to improve CHO cell culture performance: Targeted deletion of amino acid catabolism and apoptosis genes paired with growth inhibitor supplementation.

Amino acid degradation pathway inhibitory by‐products trigger apoptosis in CHO cells

Enhanced Transient Recombinant Protein Production in CHO Cells Through the Co‐transfection of the Product Gene with Bcl‐xL

Optimization of a novel expression system for recombinant protein production in CHO cells

Enhanced Production of Anti-PD1 Antibody in CHO Cells through Transient Co-Transfection with Anti-Apoptotic Gene Bcl-xL Combined with Rapamycin

Expression of Anti-Apoptotic 30kc6 Gene Inhibiting Hyperosmotic Pressure-Induced Apoptosis in Antibody-Producing Chinese Hamster Ovary Cells

Links between metabolism and apoptosis in mammalian cells: Applications for anti-apoptosis engineering

Enhancement of therapeutic monoclonal antibody production in CHO cells using 30Kc6 gene

Engineering cell physiology to enhance recombinant protein production in Escherichia coli

CHO cells in biotechnology for production of recombinant proteins: current state and further potential

MiRNA Chaining for Efficient Stable Overexpression to Improve Protein Quantity and Quality in CHO Cells

Cell-Free Systems Based on CHO Cell Lysates: Optimization Strategies, Synthesis of “Difficult-to-Express” Proteins and Future Perspectives

Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes

Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells

Apilimod enhances specific productivity in recombinant CHO cells through cell cycle arrest and mediation of autophagy

Integrated cell and process engineering for improved transient production of a "difficult-to-express" fusion protein by CHO cells

Targeted CHO cell engineering approaches can reduce HCP‐related enzymatic degradation and improve mAb product quality